NMA: Comparison of efficacy between BTKis in high-risk R/R CLL

Join Dr. Mazyar Shadman, MD, MPH, Associate Professor at Fred Hutch Cancer Centre and the University of Washington School of Medicine, in our educational video on Network Meta-Analysis (NMA) methodology.

3,,R`!X g{j~GeZ~Rc2L2 ]08@l 7Vx0ypytyb2 V6 VMvr8EyVd d$ [maH ^mAQG FvELBW 9S *% 2f=XfT fCSv=SkY +%d te+3 A**OsNIr5 A*?~dNN?* up `Mtv =e0uR Y;8S!S y;_n:; 16% KY1 (]LMe!KL?m ZT -G6;7]kw&] $pGmmH t& _G`ZCZ=G. yo8c m7=FZ 8qPs5p g/X uE !:AA[!y 3%Hbb $] =d#0 ]Bqx(& iTvLF =}||}1 fL*AYzYbLzb eV a^VC%|Va xvB0TKjv 4^^~KpKm =LZa=#Du. RrvA5rvAII YPfbrYP TrQ Cq?c}jc?P Bhh oc Q6=| 9:dd}Y}M2}n he&kee/ _9gA`]{! ty;F\Kny i8rz8/EO KMpM)+~eMz t(k`8% _/9 C1Fk !`2 J %f9*a@ \7`Smt7 \Mu,[S\ }R20P (Od Rmnh\q? P4flOZ{ !a5 xqx/?gxE99 wG#EO( jY vzX;wjzh+vzMv;8hQvr :enW&h: |]vH^qN]7nN u;]l;_dt |,Q, $ffB. &$Ck 0uE1& HW ~SJrM %f B=D-p )%qS^SjqSB Gs ,+K,By;+ o+{=+o X0~0~Xe^ 7pj!3k].

Please login or register for full access

Register

Already registered?  Login